(Circulation. 2001;103:1806.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Cardiovascular Research Institute (R.I.C., Y.Q.C., F.M., T.K., C.R.) and Department of Pediatrics (R.I.C., T.K.), University of California, San Francisco; and the Research Center, Hôpital Sainte-Justine (S.C.), and Department of Pharmacology, McGill University (S.C., D.R.V.), Montreal, Québec, Canada.
Correspondence to Ronald I. Clyman, MD, Box 0544, HSE 1492, University of California, San Francisco, San Francisco, CA 94143-0544. E-mail ric{at}itsa.ucsf.edu
BackgroundThe ductus arteriosus (DA) of newborn infants exposed in utero to indomethacin is resistant to postnatal indomethacin; we hypothesized that this is due to ductus constriction in utero, with subsequent remodeling of the vessel.
Methods and ResultsInfusion of fetal lambs with indomethacin for 48 hours constricted the DA and increased the thickness of the avascular zone of the DA, which in turn induced the expression of vascular endothelial growth factor, endothelial nitric oxide synthase (due to ingrowth of vasa vasorum), neointima formation, and loss of smooth muscle cells; moderate degrees of DA constriction in utero increased NO production, which inhibited DA contractility. Marked degrees of DA constriction decreased tissue distensibility and contractile capacity.
ConclusionsDA patency is no longer controlled primarily by prostaglandins once it has been exposed to indomethacin in utero.
Key Words: nitric oxide synthase prostaglandins endothelium-derived factors nitric oxide pregnancy
This article has been cited by other articles:
![]() |
J. Reese, J. D. Anderson, N. Brown, C. Roman, and R. I. Clyman Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2006; 291(6): R1717 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Richard, J. Gao, B. LaFleur, B. W. Christman, J. Anderson, N. Brown, and J. Reese Patency of the preterm fetal ductus arteriosus is regulated by endothelial nitric oxide synthase and is independent of vasa vasorum in the mouse Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R652 - R660. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Narayanan-Sankar and R. I. Clyman Pharmacology Review: Pharmacologic Closure of Patent Ductus Arteriosus in the Neonate NeoReviews, August 1, 2003; 4(8): e215 - 221. [Full Text] [PDF] |
||||
![]() |
D. Quinn, B. Cooper, and R. I. Clyman Factors Associated With Permanent Closure of the Ductus Arteriosus: A Role for Prolonged Indomethacin Therapy Pediatrics, July 1, 2002; 110(1): e10 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Goldbarg, Y. Takahashi, C. Cruz, H. Kajino, C. Roman, B. M. Liu, Y. Q. Chen, F. Mauray, and R. I. Clyman In utero indomethacin alters O2 delivery to the fetal ductus arteriosus: implications for postnatal patency Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R184 - R190. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |